Abstract
Post bone marrow transplant patients are susceptible to atypical infections, especially viral pathogens. The risk increases many folds in cases of allogeneic transplantation, which also receive GVHD prophylaxis. Viral pathogens like cytomegalovirus and herpes are the common ones encountered during follow-up period. However, in recent times there have been reports of a variety of disease manifestations of rare viruses like polyoma virus and adenovirus. These viral infections may play a crucial role in morbidity and mortality in immunocompromised patients. We hereby elaborate the follow-up course of a 36-year-old post allogeneic transplant patient of acute myeloid leukemia who developed adenovirus related haemorrhagic cystitis. Treatment with oral ribavirin lead to dramatic improvement in symptomatology within a week. This cases re-emphasizes the fact that after ruling out the commoner pathogens, it’s of utmost importance to strongly consider the atypical pathogens in such cases.
This is a preview of subscription content, log in via an institution to check access.
References
Brugieres L, Hartmann O, Travagli JP, Benhamou E, Pico JL, Valteau D et al (1989) Hemorrhagic cystitis following high-dose chemotherapy and bone marrow transplantation in children with malignancies: incidence, clinical course, and outcome. J Clin Oncol 7(2):194–199
Seber A, Shu XO, Defor T, Sencer S, Ramsay N (1999) Risk factors for severe hemorrhagic cystitis following BMT. Bone Marrow Transplant 23(1):35–40
La Rosa AM, Champlin RE, Mirza N, Gajewski J, Giralt S, Rolston KV et al (2001) Adenovirus infections in adult recipients of blood and marrow transplants. Clin Infect Dis 32(6):871–876
Hale GA, Heslop HE, Krance RA, Brenner MA, Jayawardene D, Srivastava DK et al (1999) Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplant 23(3):277–282
Suparno C, Milligan DW, Moss PA, Mautner V (2004) Adenovirus infections in stem cell transplant recipients: recent developments in understanding of pathogenesis, diagnosis and management. Leuk Lymphoma 45(5):873–885
Runde V, Ross S, Trenschel R, Lagemann E, Basu O, Renzing-Kohler K et al (2001) Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study. Bone Marrow Transplant 28(1):51–57
Flomenberg P, Babbitt J, Drobyski WR, Ash RC, Carrigan DR, Sedmak GV et al (1994) Increasing incidence of adenovirus disease in bone marrow transplant recipients. J Infect Dis 169(4):775–781
Akiyama H, Kurosu T, Sakashita C, Inoue T, Mori S, Ohashi K et al (2001) Adenovirus is a key pathogen in hemorrhagic cystitis associated with bone marrow transplantation. Clin Infect Dis 32(9):1325–1330
Childs R, Sanchez C, Engler H, Preuss J, Rosenfeld S, Dunbar C et al (1998) High incidence of adeno- and polyomavirus-induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporine. Bone Marrow Transplant 22(9):889–893
Thomas AE, Patterson J, Prentice HG, Brenner MK, Ganczakowski M, Hancock JF et al (1987) Haemorrhagic cystitis in bone marrow transplantation patients: possible increased risk associated with prior busulphan therapy. Bone Marrow Transplant 1(4):347–355
Mori Y, Miyamoto T, Kato K, Kamezaki K, Kuriyama T, Oku S et al (2012) Different risk factors related to adenovirus- or BK virus-associated hemorrhagic cystitis following allogeneic stem cell transplantation. Biol Blood Marrow Transplant 18(3):458–465
Kawakami M, Ueda S, Maeda T, Karasuno T, Teshima H, Hiraoka A et al (1997) Vidarabine therapy for virus-associated cystitis after allogeneic bone marrow transplantation. Bone Marrow Transplant 20(6):485–490
Lindemans CA, Leen AM, Boelens JJ (2010) How I treat adenovirus in hematopoietic stem cell transplant recipients. Blood 116(25):5476–5485
Fanourgiakis P, Georgala A, Vekemans M, Triffet A, De Bruyn JM, Duchateau V et al (2005) Intravesical instillation of cidofovir in the treatment of hemorrhagic cystitis caused by adenovirus type 11 in a bone marrow transplant recipient. Clin Infect Dis 40(1):199–201
Morfin F, Dupuis-Girod S, Mundweiler S, Falcon D, Carrington D, Sedlacek P et al (2005) In vitro susceptibility of adenovirus to antiviral drugs is species-dependent. Antivir Ther 10(2):225–229
Gavin PJ, Katz BZ (2002) Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children. Pediatrics 110(1 Pt 1):e9
Miyamura K, Hamaguchi M, Taji H, Kanie T, Kohno A, Tanimoto M et al (2000) Successful ribavirin therapy for severe adenovirus hemorrhagic cystitis after allogeneic marrow transplant from close HLA donors rather than distant donors. Bone Marrow Transplant 25(5):545–548
Cassano WF (1991) Intravenous ribavirin therapy for adenovirus cystitis after allogeneic bone marrow transplantation. Bone Marrow Transplant 7(3):247–248
Lakhani A, Raptis A, Frame D, Simpson D, Berkahn L, Mellon-Reppen S et al (1999) Intravesicular instillation of E-aminocaproic acid for patients with adenovirus-induced hemorrhagic cystitis. Bone Marrow Transplant 24(11):1259–1260
Laszlo D, Bosi A, Guidi S, Saccardi R, Vannucchi AM, Lombardini L et al (1995) Prostaglandin E2 bladder instillation for the treatment of hemorrhagic cystitis after allogeneic bone marrow transplantation. Haematologica 80(5):421–425
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sahu, K.K., Prakash, G., Khadwal, A. et al. A Rare Case of Hemorrhagic Cystitis in Allogeneic Hematopoietic Stem Cell Transplant Patient. Indian J Hematol Blood Transfus 32 (Suppl 1), 196–200 (2016). https://doi.org/10.1007/s12288-015-0530-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-015-0530-5